← Live StudiesRegistry: active, not recruitingPhase 3

KaiNETIC-3: Ribupatide compared with semaglutide

Compares once-weekly investigational ribupatide (KAI-9531) injections with once-weekly semaglutide and with placebo on body weight in adults with obesity who do not have diabetes.

This study is no longer recruiting. According to its ClinicalTrials.gov record, enrollment is complete. It is listed here for reference.

See recruiting studies View official study record

Who it's for

Age 18+
BMI ≥35
Diabetes excluded

Full eligibility rules apply. The study team decides who can take part.

Where it runs

4 research locations in Arizona and California.

Arizona

Kailera clinical site (name not disclosed)Glendale, AZ
Kailera clinical site (name not disclosed)Phoenix, AZ

California

Kailera clinical site (name not disclosed)Northridge, CA
Kailera clinical site (name not disclosed)Oceanside, CA

These sites are not enrolling new participants for this study. The official record lists every location, including outside these states.

Looking for a study that is enrolling?

See the studies that are recruiting now, or tell us you are interested in research and we will help you find one.

See recruiting studies Ask about research

Important information about clinical research

InvestigatorX is an independent information directory. Being listed here does not mean a sponsor, research institution or investigator is affiliated with InvestigatorX. ClinicalTrials.gov registration is not FDA approval of a study drug, an endorsement, or confirmation that a particular site is currently accepting participants.

Summaries are informational and do not determine clinical eligibility. Research can involve risks, including investigational medications and placebo assignment. Always review the ClinicalTrials.gov study basics and speak with a qualified healthcare professional and the authorized study team.

No medical information is collected on this page. For accurate criteria, contacts, and the latest recruitment status, select View official study record on each study's page.

Research listings compiled October 21, 2026. Source: U.S. ClinicalTrials.gov and registry-indexed study information. Independent site; not a U.S. government service. Study data can change without notice.